FDA approves dalbavancin for acute bacterial skin infections
Posted on: 23/05/2014 - 22:20
Dalbavancin is the first drug with a Qualified Infectious Disease Product designation to be approved by the Food and Drug Administration. On May 23, the agency approved dalbavancin (<link...
Field of Interest: Dermatology
Type: News Item